Addressing the Unmet Need for Novel Safe and Effective Therapies for Pain and Inflammation
Pain and inflammation represent a vast and prevalent problem, and current medications all have major limitations. There is an urgent need and opportunity for a better solution.
EicOsis Human Health aims to provide a new effective oral solution for pain and inflammation without the side effects of standard therapies and without addiction potential. We are a clinical stage company with a strong team advancing inhibitors of soluble epoxide hydrolase (sEHI) as a novel therapeutic approach. Our lead drug candidate EC5026 has completed a Phase 1a clinical study showing safety and an ideal pharmacokinetic profile as a once daily oral drug. Contact us for more information and to learn more about what’s going on at EicOsis.